Neurol. praxi. 2010;11(2):90-94

Practical experience with the clinical diagnosis of myasthenia gravis

MUDr.Jiří Pi»ha
Centrum myasthenia gravis, Neurologická klinika VFN a 1. LF UK, Praha

Myasthenia gravis is a clinically heterogeneous disease that is characterized by fluctuating muscle weakness and fatigue, which is worse

after physical exertion or mental stress. This article summarizes the most common clinical manifestations and special investigation that

aim to establish the diagnosis of initial stages of development of the disease.

Keywords: myasthenia gravis, muscle weakness, fatigue, fluctuation, diplopia, ptosis, dysphagia, dysarthria, myasthenic crisis

Published: April 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pi»ha J. Practical experience with the clinical diagnosis of myasthenia gravis. Neurol. praxi. 2010;11(2):90-94.
Download citation

References

  1. Alshekhlee A, Miles JD, Katirji B, Preston DC, Kaminski HJ. Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals. Neurology 2009; 72(18): 1548-1554. Go to original source... Go to PubMed...
  2. Burns TM, Conaway MR, Cutter GR, Sanders DB and muscle study group. Construction of an efficiant evaluation instrument for myasthenia gravis: The MG composite. Muscle Nerve 2008; 38: 1553-1562. Go to original source... Go to PubMed...
  3. De Carvalho M, Geraldes R. Longstanding right-hand weakness in a patient with myasthenia gravis. Muscle Nerve 2006; 34(5): 670-671. Go to original source... Go to PubMed...
  4. Gilhus NE. Autoimmune myasthenia gravis. Expert Rev Neurother 2009; 9(3): 351-358. Go to original source... Go to PubMed...
  5. Grob D, Brunner N, Namba T, Pagala M. Lifetime course of myasthenia gravis. Muscle Nerve 2008; 37: 141-149. Go to original source... Go to PubMed...
  6. Kusner LL, Puwanant A, Kaminski HJ. Ocular myasthenia: diagnosis, treatment, and pathogenesis. Neurologist 2006; 12(5): 231-239. Go to original source... Go to PubMed...
  7. Larner AJ. The place of the ice pack test in the diagnosis of myasthenia gravis. Int J Clin Pract 2004; 58(9): 887-888. Go to original source... Go to PubMed...
  8. Llabrés M, Molina-Martinez FJ, Miralles F. Dysphagia as the sole manifestation of myasthenia gravis. J Neurol Neurosurg Psychiatry 2005; 76(9): 1297-1300. Go to original source... Go to PubMed...
  9. Meriggioli M, Sanders DB. Autoimmune myasthenia gravis: emerging clinical and biological heterogenity. Lancet Neurol 2009; 8(5): 475-490. Go to original source... Go to PubMed...
  10. Oh SJ, Muscle-specific receptor tyrosine kinase antibody positive myasthenia gravis current status. J Clin Neurol 2009; 5: 53-64. Go to original source... Go to PubMed...
  11. Pi»ha J. Imunitně podmíněné poruchy nervosvalového přenosu. In Havrdová E. Neuroimunologie, Praha, Maxdorf, 2001: 279-295.
  12. Pi»ha J, Ambler Z. Nejčastějąí chyby a omyly v diagnostice a terapii myasthenia gravis, Neurol. pro praxi 2004; 5: 285-290.
  13. Pi»ha J. Imunopatogeneze a klinický obraz myasthenia gravis In: Schutzner J, ©mat V. Myasthenia gravis - komplexní pojetí a chirurgická léčba. Praha: Galén 2005: 19-30.
  14. Rodolico C, Toscano M, Autunno S. Limb-girdle myasthenia: clinical, electrophysiological and morphological features in familiar and autoimmune cases. Neuromuscul Disord 2002; 12: 964-969. Go to original source... Go to PubMed...
  15. Scherer K, Bedlack RS, Simel DL. Does this patient have myasthenia gravis? JAMA 2005; 293(15): 1906-1914. Go to original source... Go to PubMed...
  16. Soltys J, Gong B, Kaminski HJ, Zhou Y, Kusner L. Extraocular muscle susceptibility to myasthenia. Unique immunological environment. Ann N Y Acad Sci 2008; 1132: 220-224. Go to original source... Go to PubMed...
  17. ©palek P. Myasténia gravis. Ces Slov Neurol N 2008; 71/104: 7-24.
  18. Vincent A, Clover L, Buckley C, Grimley JE, Rothwell PM. Evidence of underdiagnosis of myasthenia gravis in older people. J Neurol Neurosurg Psychiatry 2003; 74: 1105-1108. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.